Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

Lina Sabor, Mélanie Raphaël, Jean-Michel Dogné, François Mullier, Jonathan Douxfils

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)36-38
Number of pages3
JournalThrombosis Research
Early online date2017
Publication statusPublished - 1 Aug 2017


  • Apixaban
  • Chromogenic anti-Xa assays
  • Edoxaban
  • Heparin
  • Rivaroxaban
  • Heparin/pharmacology
  • Humans
  • Blood Coagulation Tests/methods
  • Factor Xa Inhibitors/therapeutic use
  • Anticoagulants/therapeutic use

Cite this